Summary of the HTA, funding and innovation payment landscape for gastrointestinal technologies in Europe

17

Oct 2019

MTRC has developed three reports on the key market access topics, including innovation funding, health technology assessment and funding frameworks for medical devices. These reports help to understand the relevance of these frameworks to certain types of medical technologies, including gastrointestinal technologies.

Did you know that:

  • There were 6 health technology assessments of gastrointestinal technologies in 2018 in Europe;
  • These assessments were published only in 3 EU countries;
  • Only 1 assessment was published by the regional HTA bodies, the remaining were published by the national organizations;
  • There were 19 funding decisions about gastrointestinal technologies published in 3 EU with established funding frameworks countries for all time periods;
  • In 63% of the cases, funding decisions were positive in relation to gastrointestinal technologies;
  • There was 1 positive innovation funding decisions (NUB) for gastrointestinal in Germany in 2019.

By accessing one or several of our syndicated reports you can:

  • Understand the relevance of topics of innovation funding, health technology assessment and funding frameworks in the gastrointestinal field;
  • Understand, which countries are more active with HTA, funding and innovation funding for gastrointestinal devices;
  • Understand, what types of technologies typically triggers HTA or review by the funding authorities / decision-makers;
  • Understand, what gastrointestinal technologies got positive and negative funding decisions;
  • Develop fact-based market access strategies for your portfolio of devices;
  • Prioritize markets, based on the solid information about HTA and reimbursement activity for your type of product.

You can get access either to the full reports or limited to the topic of gastrointestinal devices. Download sample pages of the reports via the links provided above.

Contact us at info@mtrconsult.com to request a quote or get more information.

The latest related news

23

Mar 2023

In February 2023, the Scottish Health Technology Group, SHTG, released three MedTech-related assessments: selective internal radiation therapies (SIRT) for treating primary hepatocellular carcinoma, Feeling Good app, store-and-forward teledermatology for triage of primary care referrals.

Read more

22

Mar 2023

A new preeclampsia screening algorithm has been evaluated within the "New Method" framework since 2021. The algorithm helps to predict the risk of preeclampsia in the first trimester based on several parameters, including ultrasound examination and measurement of the Placenta Growth Factor (PIGF). In March 2023, the Decision Forum for "New Method" was held and commissioned to perform the implementation study of a new screening algorithm at St. Olav's Hospital.

Read more

21

Mar 2023

On March 8, 2023, the Ministry of Health and Prevention published an Order in the Official Journal of the French Republic on the coverage of the INTERVAPOR system for lung volume reduction under Forfait innovation program.

Read more

17

Mar 2023

On March 2, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) published the determined funding priorities for new forms of care. A total of six prioritized topics are defined. The preparation of a complete application can be supported for a period of up to six months with a grant of up to a maximum of €75,000. The deadline for submitting ideas is May 16, 2023.

Read more

16

Mar 2023

In January-February 2023, Health Technology Wales published sixteen Medtech-related Topic Exploration Reports (TER), including stereotactic radiosurgery, percutaneous implantation of pulmonary artery pressure sensors, ambulatory patch ECG devices, and others; however, Health Technology Wales will not proceed with full appraisals on these topics. No Guidance was released for Medtech in January-February 2023.

Read more